Ultrasound to be explored for delivery of RNAi therapies

Koninklijke Philips Electronics NV of the Netherlands has signed an agreement with the US discovery-stage company, RXi Pharmaceuticals, to explore the use of ultrasound for the delivery RNA interference compounds in cells.